Skip to main content
. 2018 Jul 5;103(11):1815–1824. doi: 10.3324/haematol.2018.190728

Figure 3.

Figure 3.

C-reactive protein (CRP) at onset and clinical outcome. (A) Kaplan–Meier estimation for survival from onset and (B) the cumulative incidence of ECD-related death of 34 patients with sufficient clinical data. (C) Comparison of the CRP level before and after administration of first-line therapy. (D) Kaplan–Meier estimation for survival from onset according to the decline of CRP levels after first-line therapy.